Positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) has proved valuable in the detection and staging of malignancies and in assessment of response to treatmentl4. Little has been published on the application of this technique to detection of bone marrow metastases.
CASE HISTORY
A woman aged 47 was referred in November 1996 with a lump in the upper medial quadrant of her left breast which on wide local excision and level 2 axillary dissection proved to be a 4.5 cm, grade 3, node-negative ductal carcinoma. Staging investigations, including chest X-ray, isotope bone scan and liver ultrasound yielded no evidence of secondary spread. The patient completed adjuvant chemotherapy with 5-fluorouracil, epirubicin, cisplatin and subsequent breast radiotherapy in June 1997. She returned in November 1997 with a nodule in the medial aspect of the lumpectomy scar which cytological examination showed to be malignant. When an isotope bone scan and computed tomographic (CT) scans showed no abnormalities she underwent a mastectomy and level 3 axillary clearance with removal of a 1 cm grade 3 ductal carcinoma; 4 of 23 axillary nodes showed metastases. In January 1998 the patient reported nagging discomfort in both knees and was noted to have a microcytic, hypochromic anaemia (Hb 9.1 g/dL, MCV 72.9 fL)and thrombocytopenia (platelets 95 x 109/ L). On bone scanning there was patchy uptake of isotope in the skull vault and high activity in both lower femoral ' metaphyses and diaphyses, the meaning of which was uncertain (Figure 1 ). Magnetic resonance imaging of the knees revealed widespread marrow infiltration in both distal femora and additional foci in both proximal tibiae ( Figure  2 ). On CT scans of her thorax and abdomen small nodes were seen lateral to the aorta and in the pretracheal region but these were judged more likely to be reactive than to contain metastases. No definite pulmonary deposits were seen and the remainder of the scan was unremarkable, as were plain radiographs of the femora.
The patient was then examined by 18F-FDG PET, which showed diffuse uptake in many vertebral bodies, sternum, ribs, both humeri and both femora (Figure 3 ). Appearances were those of a diffuse marrow abnormality consistent with metastatic involvement. Additionally, focal increased uptake was noted in the superior mediastinum and lung hila, consistent with lymphadenopathy. Bone marrow taken by trephine from the sternum was infiltrated with poorly differentiated carcinoma. Palliative radiotherapy was administered to both lower femora with good effect. COMMENT Conventional bone marrow biopsies indicate that about 40% of patients with metastatic breast cancer have bone marrow involvement5. Such patients are incurable with existing treatments, so the detection of marrow metastases has important prognostic and therapeutic implications.
Whole-body PET with 18F-FDG exploits the high glycolytic rate of malignant tissue compared with that of nonmalignant cells, and can uncover previously unknown metastatic disease6'7. The sensitivity for detection of malignant lesions has been reported at 87% with a positive predictive value of 94%8.
Although magnetic resonance imaging has proved superior to plain radiography and bone scans in detecting marrow involvement in solid tumours of children9 and in breast cancer10 it cannot readily be used to examine the whole body. Accumulating data suggest that PET imaging can detect metastatic disease earlier than other radiological methods, thereby possibly sparing patients additional investigations 1. The demonstration in our patient of extensive marrow involvement with PET despite normal plain radiographs and an equivocal bone scan supports this view.
Histological examination of marrow biopsy specimens is the only definitive method to evaluate marrow involvement. Unfortunately, this investigation has a low yield attributable to sparse involvement of the marrow and sampling errors. By highlighting suitable areas for biopsy, PET imaging seems to provide the oncologist with an aid to this sometimes difficult task. Though costly, it merits further investigation, especially where conventional imaging has been unhelpful. 
